In the relentless fight against malaria, particularly the deadly Plasmodium falciparum strain, late treatment failure stands as a formidable barrier to global health progress, characterized by the reappearance of malaria parasites in the bloodstream after an initially successful drug response. This
The pharmaceutical industry stands as a pillar of modern healthcare, tirelessly working to develop life-saving medications through rigorous research and development efforts that often span years and cost billions. Yet, the very system designed to protect and incentivize this innovation—the patent
In the fast-paced realm of pharmaceutical advancements, few stories capture attention like the regulatory journey of Sanofi’s tolebrutinib, a potential game-changer for non-relapsing secondary progressive multiple sclerosis (nrSPMS). This Bruton’s tyrosine kinase (BTK) inhibitor, aimed at slowing
In a remarkable stride forward for pediatric asthma treatment, a recent study has unveiled a potential game-changer: a two-in-one inhaler that combines budesonide, an inhaled corticosteroid, with formoterol, a fast-acting bronchodilator, slashing asthma attacks in children by nearly half. Known as
In the bustling economic hub of Nanjing, China, located in the heart of the Yangtze River Delta, a pressing public health challenge has emerged with the rapid spread of HIV-1 CRF119_0107, a second-generation recombinant strain derived from CRF01_AE and CRF07_BC. This variant has climbed to become
In an era where the medical technology industry grapples with unprecedented supply chain disruptions, a new player has emerged with the potential to redefine stability and innovation in this critical sector. The formation of Forj Medical, a merger between two Minnesota-based medical device
